Pharmacokinetics of ceftriaxone in buffalo calves (Bubalus bubalis) following intravenous and intramuscular administration
Authors
Abstract:
Pharmacokinetics of ceftriaxone was studied in buffalo calves (Bubalus bubalis) after single intravenousand intramuscular administration of 10 mg/kg body weight. The drug concentrations in plasma samples weremeasured by high performance liquid chromatography with UV detection. Following intravenousadministration, the drug was rapidly distributed (Cpo: 106.5 ± 9.64 μg/ml; t1/2α: 0.09 ± 0.01 h; Vdarea: 0.48 ± 0.05 L/kg) and eliminated (t1/2β: 1.27 ± 0.04 h) from the body with a clearance rate of 4.40 ± 0.44 ml/min.kg. Following intramuscular administration, the peak plasma concentration of the drug was 15.8 ± 2.4 μg/ml at 0.5 h and the drug was detected up to 12 h. The drug was rapidly absorbed from the site of injection (t1/2ka: 0.35 ± 0.01 h), widely distributed (Vdarea: 1.53 ± 0.2 L/kg) and slowly eliminated from the body (t1/2β: 4.38 ± 0.4 h; ClB: 4.01 ± 0.30 ml/min.kg). The bioavailability of ceftriaxone was 70.2 ± 2.0% following intramuscular injection. Intramuscular injection of ceftriaxone has favourable pharmacokinetics and moderate bioavailability in buffalo calves and can be used for susceptible infections in calves.
similar resources
pharmacokinetics of ceftriaxone in buffalo calves (bubalus bubalis) following intravenous and intramuscular administration
pharmacokinetics of ceftriaxone was studied in buffalo calves (bubalus bubalis) after single intravenousand intramuscular administration of 10 mg/kg body weight. the drug concentrations in plasma samples weremeasured by high performance liquid chromatography with uv detection. following intravenousadministration, the drug was rapidly distributed (cpo: 106.5 ± 9.64 μg/ml; t1/2α: 0.09 ± 0.01 h; v...
full textPharmacokinetics of cefpirome in buffalo calves (Bubalus bubalis) following single intramuscular administration
The pharmacokinetics of cefpirome was investigated in buffalo calves following its single intramuscular (IM) administration (10 mg). The peak plasma concentration of cefpirome at 30 min was 9.0 ± 0.5 μg.ml-1, which declined to 0.2 ± 0.1 μg.ml -1 at 24 hrs. The absorption half-life (t1/2Ka) and elimination half-life (t1/2 β) were 0.19 ± 0.03 hr and 2.39 ± 0.05 hr, respectively. The area under th...
full textComparative Pharmacokinetics and Dosage Regimen of Cefepime in Buffalo Calves (Bubalus bubalis) following Intravenous and Intramuscular Administration
The disposition kinetics and dosage regimen of cefepime were compared after its intravenous and intramuscular administration at 10 mg.kg-1 in healthy buffalo calves. The drug concentration in plasma was estimated by microbiological assay. The peak plasma concentration of cefepime after intravenous injection was at 1 min (46.4 ± 0.40 g.ml-1) and after intramuscular administration it was at afte...
full textPharmacokinetics of ceftazidime in buffalo calves following intravenous and intramuscular administration
The pharmacokinetic parameters of ceftazidime, a third generation cephalosporin, were investigated in six buffalo calves after single intravenous (IV) and intramuscular (IM) administration at a dose rate of 10 mg/kg body weight. Ceftazidime concentrations in plasma and urine were determined by microbiological assay. Ceftazidime disposition was best fitted by a two-compartmental and a one-compar...
full textpharmacokinetics of cefpirome in buffalo calves (bubalus bubalis) following single intramuscular administration
the pharmacokinetics of cefpirome was investigated in buffalo calves following its single intramuscular (im) administration (10 mg). the peak plasma concentration of cefpirome at 30 min was 9.0 ± 0.5 μg.ml-1, which declined to 0.2 ± 0.1 μg.ml -1 at 24 hrs. the absorption half-life (t1/2ka) and elimination half-life (t1/2 β) were 0.19 ± 0.03 hr and 2.39 ± 0.05 hr, respectively. the area under th...
full textDisposition Kinetics and Urinary Excretion of Paracetamol Following Intravenous Administration in Buffalo Calves (Bubalus bubalis)
Paracetamol (Acetaminophen), a NSAID is well tolerated and lacks many side effects of aspirin. It is a widely used over-the-counter analgesic, antipyretic and weak anti-in ammatory property. The main mechanism is the inhibition of cyclooxygenase (COX) and recent ndings suggest that it is highly selective for COX-2 (Henz et al., 2008). The present study was aimed to study the disposition kine...
full textMy Resources
Journal title
volume 10 issue 1
pages 33- 37
publication date 2009-03-20
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023